Tanaka A - Search Results

1

Roles of endogenous prostaglandins and cyclooxygenase isozymes in healing of indomethacin-induced small intestinal lesions in rats.

Hatazawa R, Ohno R, Tanigami M, Tanaka A, Takeuchi K. Hatazawa R, et al. Among authors: tanaka a. J Pharmacol Exp Ther. 2006 Aug;318(2):691-9. doi: 10.1124/jpet.106.103994. Epub 2006 May 12. J Pharmacol Exp Ther. 2006. PMID: 16699067

2

Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage.

Tanaka A, Hase S, Miyazawa T, Takeuchi K. Tanaka A, et al. J Pharmacol Exp Ther. 2002 Mar;300(3):754-61. doi: 10.1124/jpet.300.3.754. J Pharmacol Exp Ther. 2002. PMID: 11861778

3

16,16-Dimethyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors.

Kunikata T, Tanaka A, Miyazawa T, Kato S, Takeuchi K. Kunikata T, et al. Among authors: tanaka a. Dig Dis Sci. 2002 Apr;47(4):894-904. doi: 10.1023/a:1014725024519. Dig Dis Sci. 2002. PMID: 11991626

4

Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.

Tanaka A, Hase S, Miyazawa T, Ohno R, Takeuchi K. Tanaka A, et al. J Pharmacol Exp Ther. 2002 Dec;303(3):1248-54. doi: 10.1124/jpet.102.041715. J Pharmacol Exp Ther. 2002. PMID: 12438549

5

Induction of small intestinal damage in rats following combined treatment with cyclooxygenase-2 and nitric-oxide synthase inhibitors.

Ohno R, Yokota A, Tanaka A, Takeuchi K. Ohno R, et al. Among authors: tanaka a. J Pharmacol Exp Ther. 2004 Aug;310(2):821-7. doi: 10.1124/jpet.104.065961. Epub 2004 Mar 25. J Pharmacol Exp Ther. 2004. PMID: 15044560

6

Functional mechanism underlying cyclooxygenase-2 expression in rat small intestine following administration of indomethacin: relation to intestinal hypermotility.

Tanaka A, Matsumoto M, Hayashi Y, Takeuchi K. Tanaka A, et al. J Gastroenterol Hepatol. 2005 Jan;20(1):38-45. doi: 10.1111/j.1440-1746.2004.03520.x. J Gastroenterol Hepatol. 2005. PMID: 15610444

7

Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.

Yokota A, Taniguchi M, Takahira Y, Tanaka A, Takeuchi K. Yokota A, et al. Among authors: tanaka a. J Pharmacol Exp Ther. 2005 Jul;314(1):302-9. doi: 10.1124/jpet.105.084962. Epub 2005 Apr 14. J Pharmacol Exp Ther. 2005. PMID: 15831440

8

Development of intestinal, but not gastric damage caused by a low dose of indomethacin in the presence of rofecoxib.

Yokota A, Taniguchi M, Tanaka A, Takeuchi K. Yokota A, et al. Among authors: tanaka a. Inflammopharmacology. 2005;13(1-3):209-16. doi: 10.1163/156856005774423755. Inflammopharmacology. 2005. PMID: 16259740

9

Role of endogenous nitric oxide (NO) and NO synthases in healing of indomethacin-induced intestinal ulcers in rats.

Takeuchi K, Hatazawa R, Tanigami M, Tanaka A, Ohno R, Yokota A. Takeuchi K, et al. Among authors: tanaka a. Life Sci. 2007 Jan 2;80(4):329-36. doi: 10.1016/j.lfs.2006.09.016. Epub 2006 Sep 23. Life Sci. 2007. PMID: 17045617

10

Preconditioning stress prevents cold restraint stress-induced gastric lesions in rats: roles of COX-1, COX-2, and PLA2.

Tanaka A, Hatazawa R, Takahira Y, Izumi N, Filaretova L, Takeuchi K. Tanaka A, et al. Dig Dis Sci. 2007 Feb;52(2):478-87. doi: 10.1007/s10620-006-9394-8. Epub 2007 Jan 17. Dig Dis Sci. 2007. PMID: 17226073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,407 results

Search Page

Filters